SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
ZNTL
--
0.00%
--
Zentalis Pharma prices equity offering at $35
Zentalis Pharmaceuticals (NASDAQ:ZNTL) has priced its public offering of 4,125,000 common shares at $35.00/share, for total gross proceeds of ~$144.4M. Und
seekingalpha · 3d ago
Zentalis Pharmaceuticals Announces Pricing of Upsized Offering of Common Stock
NEW YORK and SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of c
GlobeNewswire · 4d ago
Celsion Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha · 5d ago
Zentalis Pharma launches equity offering
Seeking Alpha · 6d ago
Zentalis Pharmaceuticals Announces 3.75M Share Proposed Public Offering Of Common Stock
Benzinga · 6d ago
Zentalis Pharmaceuticals Announces Proposed Public Offering of Common Stock
NEW YORK and SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of c
GlobeNewswire · 6d ago
Zentalis teams up with Lilly in breast cancer study
Seeking Alpha · 07/27 12:00
Zentalis Pharmaceuticals Enters Into Clinical Collaboration With Eli Lilly & Co. To Evaluate Its Oral SERD ZN-c5 In Combination With Abemaciclib
Benzinga · 07/27 11:13
Zentalis Pharmaceuticals Enters into Clinical Collaboration with Eli Lilly and Company to Evaluate its Oral SERD ZN-c5 in Combination with Abemaciclib, a CDK4 and 6 Inhibitor
NEW YORK & SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of can
GlobeNewswire · 07/27 11:00
Zentalis Pharmaceuticals Announces the Appointment of Dr. Kimberly Blackwell to its Board of Directors
Zentalis Pharmaceuticals, Inc. (ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the appointment of Kimberly Blackwell, M.D
GlobeNewswire · 07/01 11:00
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25)
Benzinga · 06/26 12:28
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17)
Benzinga · 06/18 12:34
Zentalis Pharmaceuticals To Present Preclinical Data On ZN-c5 At Upcoming AACR Virtual Annual Meeting II Jun. 22
NEW YORK and SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics
Benzinga · 06/15 20:32
Zentalis Pharmaceuticals to Present Preclinical Data on ZN-c5 at the Upcoming AACR Virtual Annual Meeting II
NEW YORK and SAN DIEGO, June 15, 2020 -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small.
GlobeNewswire · 06/15 20:30
Is It Too Late to Jump In on Zentalis?
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
Motley Fool · 06/03 11:07
72 Biggest Movers From Friday
Gainers Adaptimmune Therapeutics plc (NASDAQ: ADAP) shares jumped 127.8% to close at $11.07 on Friday after the company announced updated data from its ADP-A2M4 Phase 1 trial at the American Society for Clinical Oncology Annual Meeting.
Benzinga · 06/01 08:53
Zentalis Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
GlobeNewswire · 05/28 21:05
Zentalis Pharmaceuticals and Tavros Therapeutics Announce Strategic Platform Collaboration to Discover Next Generation Targeted Small Molecule Therapies
GlobeNewswire · 05/28 12:00
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.)
Benzinga · 05/21 12:01
Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint Venture, Zentera Therapeutics
Zentalis Pharmaceuticals, Inc. (ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the closing of a $20 million Series A fina
GlobeNewswire · 05/20 11:00